Inmed
Non-Profit & Charitable Organizations · Virginia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
20110 Ashbrook Pl Ste 260, Ashburn, Virg...Phone Number
(703) 729-4951Website
www.inmed.orgRevenue
$24.6 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Inmed
For too many children around the world, their hope for the future is not matched by opportunity. Facing poverty, poor health, malnutrition and lack of education, living in broken families and violent communities, a generation of children is at risk. Through a broad range of health, social, education, violence prevention and community development programs, INMED is helping to create opportunities that inspire hope, build self-reliance and encourage community collaboration. Together with the company's partners, the company is transforming the future for hundreds of thousands of children and their family and community members in Latin America and the Caribbean, southern Africa, and the U.S. by: Through INMEDs programs, the process of transformation that begins with a child carries over to his family and community, creating real, meaningful, sustainable change that crosses generations, breaks the cycle of poor outcomes and leads to a brighter future for all.Explore more
Inmed Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Inmed your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Inmed, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Inmed
Product Launch: Get notified when Inmed launches new products
Click to see if Inmed had a recent Job posting/layoffs
Check if Inmed has recently received funding, and reach out quickly before it becomes old news!
Check out if Inmed is spiking on competitors!
Earning: See what the market has to say on Inmed recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Inmed has new funding data
Recommended Actions
Find VP level buyers at Inmed
Find 3 more new buyers
Company Profile Activity
Activity Insights
Inmed is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Inmed is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Inmed.
Inmed financials insights
Gather financial insights about Inmed, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
Inmed Tech Stack
A closer look at the technologies used by Inmed
Inmed News & Media
InMed Pharmaceuticals Reports Net Sales Of $575K For 6 Months Since BayMedica Acquisition
InMed Pharmaceuticals Inc. (NASDAQ:INM), a leader in research, development, manufacturing and commercialization of rare cannabinoids, released unaudited financial results for the third quarter of the fiscal year 2022 which ended March 31, 2022. read moreInMed Expands Patent Portfolio with Novel Cannabinoid Analogs and Advances Collaboration Agreement with Leading Cannabinoid Research Expert
VANCOUVER, British Columbia and SOUTH SAN FRANCISCO, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, is pleased to announce the publication of a patent application in North America for several cannabinoid analogs. This patent application has broad claims directed to their molecular structure, uses and methods of manufacturing.InMed Pharmaceuticals Strengthens its Commercial Leadership Team with the Appointment of Vice President of Sales and Marketing for BayMedica
VANCOUVER, British Columbia, Feb. 15, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, is pleased to announce the appointment of Gerard (Jerry) P. Griffin III as Vice President of Sales and Marketing at BayMedica, a wholly owned subsidiary of InMed. Mr. Griffin will oversee the commercialization of BayMedica’s health and wellness business including the exi
Read more news
Top Non-Profit & Charitable Organizations Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Inmed
Sign Up For FreeTo access detailed company insights
For too many children around the world, their hope for the future is not matched by opportunity. Facing poverty, poor health, malnutrition and lack of education, living in broken families and violent communities, a generation of children is at risk. Through a broad range of health, social, education, violence prevention and community development pr... Read More
